HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic impact of Ki-67 labeling index in minimally invasive follicular thyroid carcinoma.

Abstract
We investigated the prognostic impact of the Ki-67 labeling index (LI) in minimally invasive follicular thyroid carcinoma (FTC). We enrolled 192 patients (including four with distant metastasis at diagnosis) who were pathologically diagnosed as having minimally invasive FTC between 1998 and 2007 at Kuma Hospital. When the Ki-67 LI was higher than 5% in the hot area, we regarded it as a high Ki-67 LI. In a univariate analysis, patient age (≥45 years), high-frequent vascular invasion (≥4 in H&E specimens), and high Ki-67 LI significantly predicted the disease-free survival (DFS) of the patients. Since none of the patients <45 years old showed a recurrence, we performed a multivariate analysis of variables other than patient age. In the multivariate analysis including the presence of vascular invasion, high Ki-67 LI was an independent predictor of carcinoma recurrence. However, in the multivariate analysis including high-frequent vascular invasion, only high-frequent vascular invasion independently affected the DFS. These findings suggest that the Ki-67 LI has a rather strong prognostic value for the DFS of patients, although its impact was less than those of patient age and high-frequent vascular invasion.
AuthorsYasuhiro Ito, Mitsuyoshi Hirokawa, Akira Miyauchi, Hiroo Masuoka, Tomonori Yabuta, Mitsuhiro Fukushima, Minoru Kihara, Takuya Higashiyama, Kaoru Kobayashi, Akihiro Miya
JournalEndocrine journal (Endocr J) Vol. 63 Issue 10 Pg. 913-917 (Oct 29 2016) ISSN: 1348-4540 [Electronic] Japan
PMID27432822 (Publication Type: Journal Article)
Chemical References
  • Ki-67 Antigen
Topics
  • Adenocarcinoma, Follicular (diagnosis, metabolism, pathology)
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Ki-67 Antigen (metabolism)
  • Male
  • Middle Aged
  • Neoplasm Invasiveness
  • Predictive Value of Tests
  • Prognosis
  • Staining and Labeling (methods)
  • Thyroid Neoplasms (diagnosis, metabolism, pathology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: